MedTrace Logo

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

NCT02243319 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-10-20

No results posted yet for this study

Summary

The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904

Conditions

  • Healthy

Interventions

DRUG

HGP1201

DRUG

HGP0904

DRUG

HGP0904 and HGP1201 co-administraion

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Principal Investigators

  • Hyeong-Seok Lim, MD PhD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02243319 on ClinicalTrials.gov